politics #Healthcare #Policy #EliLilly #GLP1Drugs #Obesity #Psoriasis #Taltz #WeightLossDrugs #Zepbound GLP-1 combination therapy may unlock new benefits for psoriasis patients The Hill 11h ago
technology #Health #ClinicalTrial #EliLilly #GIP #GLP1 #Glucagon #Obesity #Retatrutide Most powerful obesity drug yet: People lost up to 25% of weight in trial Ars Technica Sep 29
politics #Healthcare #Policy #Cagrilintide #CagriSema #EliLilly #Fda #GLP1Drugs #NextGeneration #NovoNordisk #Semaglutide #Tirzepatide #Wegovy #WeightLossDrugs #Zepbound Novo Nordisk's next-gen weight loss drug outperforms Zepbound in new trial The Hill Sep 28
BURST